Innocan Pharma Corp. buy Maxi_Scalibusa
Start price
23.01.21
/
50%
€0.31
Target price
23.01.22
€6.00
Performance (%)
33.11%
End price
24.01.22
€0.41
Summary
This prediction ended on 24.01.22 with a price of €0.41. The BUY prediction by Maxi_Scalibusa for Innocan Pharma Corp. saw massive gains of 33.11%. Maxi_Scalibusa has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Innocan Pharma Corp. | - | - | - | - |
| iShares Core DAX® | 0.855% | 0.389% | 2.533% | 52.003% |
| iShares Nasdaq 100 | -0.989% | -4.400% | 25.154% | 77.536% |
| iShares Nikkei 225® | -1.781% | -11.216% | 44.398% | 64.676% |
| iShares S&P 500 | 0.057% | 0.778% | 20.953% | 63.009% |
According to Maxi_Scalibusa what are the pros and cons of Innocan Pharma Corp. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by Maxi_Scalibusa for this prediction
In the thread Innocan Pharma Corp. diskutieren
In the thread Trading Innocan Pharma Corp.
Die von Maxi_Scalibusa gewählte maximale Laufzeit wurde überschritten